FindTrial
Sign In

Comparison of MELD 3.0, MELD-Sodium, and MELD scores for predicting survival in patients with liver cirrhosis in South India.

To study the prognostic accuracy of MELD 3.0 versus MELD-Na and MELD in South Indian patients with cirrhosis at a tertiary care centre. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104519
Enrollment
114
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K74- Fibrosis and cirrhosis of liver

Interventions

Intervention1: Nil: Nil

Sponsors

Department of General Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients were identified cirrhosis using ICD 10 codes and with radiological , liver stiffness and/or biopsy of liver sample.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To compare the prognostic performance of MELD 3.0 with MELD-Na and MELD scores in predicting 1, 3, and 6-month mortality in hospitalized patients with cirrhosis in KLE S DR. PRABHAKAR KORE HOSPITAL & MRC, BELAGAVI.Timepoint: 1,3,6 months—

Secondary

MeasureTime frame
To externally validate the MELD 3.0 score for predicting mortality at 1, 3, and 6 months in the South Indian population. Timepoint: 1,3,6 months—

Countries

India

Contacts

Public ContactDr Siddharth P V M

Kle Jawaharlal Nehru Medical College

sharveel@yahoo.co.in9845710945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026